{"nctId":"NCT01515345","briefTitle":"Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry","startDateStruct":{"date":"2011-07"},"conditions":["Platelet Inhibition","Coronary Stent Implantation"],"count":1008,"armGroups":[{"label":"standard therapy","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Clopidogrel"]},{"label":"individualized therapy","type":"EXPERIMENTAL","interventionNames":["Drug: prasugrel or ticagrelor"]}],"interventions":[{"name":"prasugrel or ticagrelor","otherNames":["Efient","Brilique"]},{"name":"Clopidogrel","otherNames":["Plavix"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* all consecutive PCI patients with stent implantation of our institution\n\nExclusion Criteria:\n\n* pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Definite Stent Thrombosis","description":"The angiographic or pathological confirmation of stent thrombosis is called \"definite stent thrombosis\"","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Any Bleeding Event","description":"Bleeding classified by the TIMI hemorrhage classification scheme:\n\nMinor: any clinically overt sign of hemorrhage (including imaging) that is associated with a hemoglobin drop of 3 to \\< 5 g/dL\n\nMajor: (1) if it is intracranial, or (2) clinically significant overt signs of hemorrhage associated with a drop inhemoglobin of \\> 5 g/dL","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]},{"type":"SECONDARY","title":"Probable Stent Thrombosis","description":"Probable stent thrombosis is considered to have occurred in case of\n\n1. any unexplained death within the first 30 days.\n2. any MI that is related to documented acute ischemia in the territory of the implanted stent without angiographic confirmation of stent thrombosis and in the absence of any other obvious cause, irrespective of the time after the index procedure","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":26,"n":664},"commonTop":[]}}}